The National Asthma Council Australia (NAC) welcomes the Therapeutic Goods Administration (TGA) registration of budesonide/formoterol as reliever therapy for adults with mild asthma.
NAC CEO Siobhan Brophy says the TGA approval is an essential first step in considering whether international developments around as-needed budesonide/formoterol and treatment options for mild asthma could be implemented locally.
'The NAC is currently working on how this treatment fits in the Australian context for the next Australian Asthma Handbook update...as always, deliberations utilise well-established and rigorous protocols to determine recommendations for inclusion,' says Ms Brophy.
Fluticasone furoate has been listed on the Pharmaceutical Benefits Scheme with NAC CEO Siobhan Brophy saying the reimbursement represents additional treatment options that can help improve quality of life for Australians with asthma and welcoming the news for patients.
Dr Kimberley Wang is driven by a curiosity about early origins.
We caught up with the 2019 recipient of the Asthma and Airways Career Development Fellowship, a joint initiative with the Thoracic Society of Australia and New Zealand, to learn about what motivates her work.
NAC welcomes the recent signing of a Memorandum of Understanding between the Pharmaceutical Society of Australia and Society of Hospital Pharmacists of Australia.
NAC Chair Dr Joanna Wriedt says NAC looks forward to the opportunity this presents for all three organisations to enhance support for pharmacists to provide the highest standard of asthma care across professional settings.
Do you work with patients in the Goulburn Valley? People with complex healthcare needs in select areas could be eligible for a home energy upgrade through the Victorian Healthy Homes Program.
It's a Sustainability Victoria initiative to improve indoor winter temperatures while reducing energy bills. Recruitment is now open in Greater Shepparton, Strathbogie, Campaspe and Moira. Eligibility criteria apply.